Metabolic Testing Market, By Product Type (Metabolic Carts, Body Composition Analyzers, ECGs/EKGs), By Test Type (VO2 Max Analysis, RMR Analysis, Body Composition Analysis), By End User (Hospitals and Clinics, Sports Performance Lab, Home Care Settings), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024

Code : CMI1652

Pages :179

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Metabolic Testing Market Size and Trends

Global metabolic testing market is estimated to be valued at USD 726.2 Mn in 2024 and is expected to reach USD 1,188.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

Metabolic Testing Market Key Factors

To learn more about this report, request sample copy

The increasing prevalence of obesity and growing geriatric population are expected to boost demand for metabolic testing. Rising awareness about physical fitness and growing adoption of healthy lifestyle habits are also anticipated to boost the need for regular metabolic checks. The technological advancements in metabolic testing devices offering improved accuracy, fast results and portability can drive the market growth.

Increasing Launch of Metabolic Carts by Market Players

Global metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing launches of new metabolic carts. For instance, in May 2021, Lumen, a healthtech company, in collaboration with San Francisco State University, Lumen had validated an ongoing study launched in 2020, which showed the validity of Lumen to detect changes in metabolic fuel utilization in a comparable manner with a laboratory standard metabolic cart, providing the ability for real-time metabolic information for users under any circumstances. Lumen has made metabolic testing accessible to measure metabolism from home via the CO₂ exhaled from the breath.

/p>Increasing Prevalence of Lifestyle Diseases

Global metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing prevalence of lifestyle diseases such as type 2 diabetes, obesity, and cardiovascular diseases. For instance, on July 28, 2022, according to the data published by American Diabetes Association (ADA), around 37.3 million people in the U.S. suffered from diabetes in 2019. Whereas, nearly 1.9 million U.S. people had type 1 diabetes, including about 244,000 children and adolescents. Increasing prevalence of lifestyle diseases boosts demand for metabolic testing, and this can drive the global metabolic testing market growth.